Phase III Study of Hypofractionated, Dose Escalation Radiotherapy vs. Conventional Pelvic Radiation Therapy followed by High Dose Rate Brachytherapy Boost for High Risk Adenocarcinoma of the Prostate (PCS VI): Acute Toxicity Results

التفاصيل البيبلوغرافية
العنوان:	Phase III Study of Hypofractionated, Dose Escalation Radiotherapy vs. Conventional Pelvic Radiation Therapy followed by High Dose Rate Brachytherapy Boost for High Risk Adenocarcinoma of the Prostate (PCS VI): Acute Toxicity Results
المؤلفون:	Niazi, T.M., Vincent, F., Malagon, T., Jolicoeur, M., Yousuf, J., Delouya, G., Martin, A.G., Duclos, M., Lock, M.I., Bahoric, B., Kamran, A., Archambault, R., Amjad, A., Nabid, A.
المصدر:	In International Journal of Radiation Oncology, Biology, Physics 1 October 2023 117(2) Supplement:S26-S26
قاعدة البيانات:	ScienceDirect

الوصف
تدمد:	03603016
DOI:	10.1016/j.ijrobp.2023.06.284